Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy) (AF-EduApp)
Atrial Fibrillation and Flutter
About this trial
This is an interventional treatment trial for Atrial Fibrillation and Flutter focused on measuring Education, Application, Adherence
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years.
- Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, holter,...).
- Patients who are capable to sign the informed consent.
Exclusion Criteria:
- Not able to speak and read Dutch.
- Cognitive impaired (e.g. severe dementia).
- Life expectancy is estimated to be less than 1 year.
- Ongoing participation in another clinical trial.
- Pregnant women
Sites / Locations
- Antwerp University Hospital
- Jessa Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
No Intervention
Application-driven education (AF-EduApp substudy)
In-person education (AF-EduCare study)
Online education (AF-EduCare study)
Standard care (AF-EduCare study and AF-EduAppsub study)
Education will be given via a newly developed application. Medication adherence (oral anticoagulation) will be measured using a special bottle cap that fits on a medication bottle. The patients in this group will receive feedback (notification and/or alarm) during the entire study period via this application when these patients have to take their medication.
Education will be given on regular basis via predefined consultation visits. Medication adherence (oral anticoagulation) will also be measured using a special bottle cap that fits on a medication bottle. If adherence is low, the patient will get additional feedback when he does not take this medication as prescribed.
Education will be given on regular basis via a special designed online platform. Medication adherence (oral anticoagulation) will also be measured using a special bottle cap that fits on a medication bottle. If adherence is low, the patient will get additional feedback when he does not take this medication as prescribed.
This group of AF patients will serve as a control group and no extra focused educational reinforcements will be provided beyond standard care (i.e. information of the treating physician and a brochure).